Cargando…
Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis
INTRODUCTION: Management of patent ductus arteriosus (PDA) in preterm infants is one of the most controversial topics in neonatal medicine. The availability of different pharmacotherapeutic options often poses a practical challenge to the practising neonatologist as to which one to choose as a thera...
Autores principales: | Mitra, Souvik, Florez, Ivan D, Tamayo, Maria E, Aune, Dagfinn, Mbuagbaw, Lawrence, Veroniki, Areti-Angeliki, Thabane, Lehana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964163/ https://www.ncbi.nlm.nih.gov/pubmed/27456327 http://dx.doi.org/10.1136/bmjopen-2016-011271 |
Ejemplares similares
-
Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)
por: Mitra, Souvik, et al.
Publicado: (2021) -
Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews
por: Mitra, Souvik, et al.
Publicado: (2023) -
Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications
por: Backes, Carl H., et al.
Publicado: (2016) -
Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA
por: Yarboro, Michael T., et al.
Publicado: (2021) -
iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants
por: Namba, Fumihiko, et al.
Publicado: (2023)